Journal
CANCER COMMUNICATIONS
Volume 41, Issue 11, Pages 1195-1227Publisher
WILEY
DOI: 10.1002/cac2.12218
Keywords
Chinese Society of Clinical Oncology; CSCO; Nasopharyngeal carcinoma; Diagnosis; Staging; Risk; Radiotherapy; Chemotherapy; Surgery; Immunotherapy
Categories
Ask authors/readers for more resources
The Chinese Society of Clinical Oncology (CSCO) formed a multidisciplinary team to develop comprehensive guidelines for the diagnosis and management of nasopharyngeal carcinoma (NPC) in order to improve the management of NPC.
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the diagnosis and management of NPC, the Chinese Society of Clinical Oncology (CSCO) arranged a multi-disciplinary team comprising of experts from all sub-specialties of NPC to write, discuss, and revise the guidelines. Based on the findings of evidence-based medicine in China and abroad, domestic experts have iteratively developed these guidelines to provide proper management of NPC. Overall, the guidelines describe the screening, clinical and pathological diagnosis, staging and risk assessment, therapies, and follow-up of NPC, which aim to improve the management of NPC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available